Weight loss
Semaglutide for weight loss.
Compounded semaglutide is a weekly GLP-1 injection that a licensed partner clinician may prescribe for weight management once care goes live. It is compounded, not a branded FDA-approved product.
- Compounded
- Injectable
- Weekly
- Coming soon
FDA status. Compounded semaglutide is not FDA-approved. FDA does not review compounded drugs for safety, effectiveness or quality before they are sold, and a compounded version is not a generic of Wegovy or Ozempic.

- Form
- Injection
- Schedule
- Once a week
- Price
- Set by clinical partner
- Availability
- Coming soon
Everything you need, included
- An online visit with a licensed clinician
- Your medication, if prescribed
- Supplies and discreet shipping
- Messages with your care team
Care is not live yet. When it opens, a licensed clinician reviews your health history before anything is prescribed.
What it is.
Semaglutide acts like GLP-1, a gut hormone that helps control appetite and blood sugar. Wegovy and Ozempic are FDA-approved branded semaglutide products.[1]
A compounded version is made by a licensed pharmacy for one patient's prescription. FDA says compounded drugs are not FDA-approved, and the agency does not review them for safety, effectiveness or quality before they are marketed.[2][3]
FDA also warns that some compounders use salt forms, such as semaglutide sodium or semaglutide acetate. FDA treats these as different active ingredients from the one in approved products.[2]
What clinicians consider.
A licensed clinician looks at your full picture before deciding anything. These are the kinds of questions they ask. They are not a diagnosis.
- Your weight history, current weight and health goals
- Conditions linked to weight, such as high blood pressure or type 2 diabetes
- Your personal and family medical history, including thyroid cancer
- Other medicines you take, especially insulin or medicines that raise insulin
- Past use of GLP-1 medicines and how you tolerated them
- Pregnancy, plans for pregnancy or breastfeeding
What the evidence says.
Compounded semaglutide is not FDA-approved. FDA does not review compounded drugs for safety, effectiveness or quality before they are sold, and a compounded version is not a generic of Wegovy or Ozempic.
In the STEP 1 trial, adults without diabetes who took branded semaglutide 2.4 mg weekly for 68 weeks lost an average of 14.9% of body weight, compared with 2.4% on placebo. All participants also had a lifestyle program. This trial studied the FDA-approved branded product, not compounded semaglutide.[4]
Nausea and diarrhea were the most common side effects in STEP 1. They were usually mild to moderate and eased over time.[4]
Limits. The trial results above come from the branded FDA-approved product. No trial of that size has tested compounded semaglutide, and compounded products can differ in ingredient form, strength and quality. Results differ from person to person.
Risks and when to get help.
The branded label carries a boxed warning: semaglutide caused thyroid C-cell tumors in rodents. It is unknown whether it causes these tumors, including medullary thyroid carcinoma, in people.[1]
The label also lists acute pancreatitis, gallbladder disease, low blood sugar when used with insulin or similar medicines, kidney injury from dehydration, and a risk of breathing in stomach contents during anesthesia or deep sedation.[1]
FDA has received reports of adverse events linked to dosing errors with compounded semaglutide, some needing hospital care. As of May 31, 2026, FDA had received 990 adverse event reports tied to compounded semaglutide.[2]
Tell a clinician if
- Tell a clinician if you or a family member has had medullary thyroid carcinoma or MEN 2.
- Tell a clinician if you have had pancreatitis or gallbladder disease.
- Tell a clinician if you take insulin or a sulfonylurea.
- Tell a clinician if you have diabetic eye disease or kidney problems.
- Tell a clinician if you are pregnant, plan to become pregnant or are breastfeeding.
- Tell a clinician before any surgery or procedure that needs anesthesia or sedation.
Get urgent care if
- Severe stomach pain that does not go away, with or without vomiting
- Swelling of the face, lips, tongue or throat, or trouble breathing
- Vomiting or diarrhea so bad that you cannot keep fluids down
- Signs of low blood sugar, such as shaking, sweating or confusion
- A lump or swelling in your neck, or trouble swallowing
What care will include.
- An online health history reviewed by a licensed partner clinician
- A clinician's decision on whether compounded semaglutide is appropriate for you
- If prescribed, a patient-specific prescription filled by a licensed pharmacy
- Dosing and injection guidance from the partner care team
- Follow-up to review side effects and progress
What Livozo does not do
- Livozo does not prescribe, diagnose or dispense medication.
- Livozo does not decide whether a treatment is right for you. A licensed partner clinician makes that decision.
- Livozo does not promise a prescription, a delivery date or a result.
- Livozo does not offer this treatment today. Care is not live.
Cost.
Coming soon. There is no checkout today. Livozo's planned platform subscription is $39 the first month, then $79 each month. Medication is billed separately by the clinical partner at their price. Livozo does not mark up medicine.
What a price should include
- Livozo's planned platform subscription ($39 the first month, then $79 each month)
- The licensed partner clinician's review
- The medication itself, billed by the clinical partner at their price if prescribed
- Needles, syringes and other supplies
- Shipping from the licensed pharmacy
- Lab tests, if a clinician orders them
- Follow-up visits and messages
Availability.
Coming soon. Compounded semaglutide will be available through licensed clinicians when care opens. Care is not live in any state today. After launch, the target is 50-state coverage through licensed partner clinicians. Louisiana and Mississippi block shipping of compounded GLP-1s. This product will not ship to Louisiana or Mississippi.
Review and sources.
- Written by
- Livozo Editorial
- Medical review
- TODO(clinical) Reviewer pending. See review status
- Published
- Last updated
- Next review
- Set at clinical sign-off
Questions about Semaglutide.
- Is compounded semaglutide the same as Wegovy?
- No. Wegovy is an FDA-approved branded product. Compounded semaglutide is not FDA-approved, is not a generic of Wegovy or Ozempic, and FDA does not review it for safety, effectiveness or quality before it is sold.
- Can I get semaglutide from Livozo today?
- No. Care is not live in any state today. When it goes live, a licensed partner clinician will decide whether semaglutide is appropriate for you.
- How much will it cost?
- Coming soon. Livozo's planned platform subscription is $39 the first month, then $79 each month. Medication, if prescribed, is billed separately by the clinical partner at their price. Livozo does not mark up medicine. See the Pricing page. There is no live billing today.
- Will the weight-loss results from studies apply to me?
- Not necessarily. The large trials studied the branded FDA-approved product, not compounded semaglutide, and results vary from person to person.
- Can it ship to every state?
- The target after launch is 50-state coverage. Louisiana and Mississippi block shipping of compounded GLP-1s. It will not ship to Louisiana or Mississippi.